Showing results (981-990 of 1,115) with videos related to
Sort By:
Pageof 112
Leukemia Research|November 26, 2008
Array CGH analysis of chronic lymphocytic leukemia reveals frequent cryptic monoallelic and biallelic deletions of chromosome 22q11 that include the PRAME geneShelly R Gunn, Aswani R Bolla, Lynn L Barron, et al.Cancer|February 28, 2006
Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemiaDeborah A Thomas, Stefan Faderl, Susan O'Brien, et al.Blood|June 26, 2008
Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemiaLaura Z Rassenti, Sonia Jain, Michael J Keating, et al.Blood|February 25, 2006
Eradication of minimal residual disease in hairy cell leukemiaFarhad Ravandi, Jeffrey L Jorgensen, Susan M O'Brien, et al.Leukemia|May 18, 2018
Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategiesPhilip A Thompson, Christine B Peterson, Paolo Strati, et al.Kidney International|May 27, 2020
Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosisZhongyang Zhang, Madhav C Menon, Weijia Zhang, et al.Blood|October 11, 2003
Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylateDeborah A Thomas, Stefan Faderl, Jorge Cortes, et al.BMC Medical Genetics|February 16, 2017
Genetic analysis of impaired trimethylamine metabolism using whole exome sequencingYiran Guo, Liang-Dar Hwang, Jiankang Li, et al.The Lancet. Oncology|October 5, 2019
Time-to-progression after front-line fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy for chronic lymphocytic leukaemia: a retrospective, multicohort studyCarmen D Herling, Kevin R Coombes, Axel Benner, et al.Frontiers in Genetics|April 12, 2014
Return of results in the genomic medicine projects of the eMERGE networkIftikhar J Kullo, Ra'ad Haddad, Cynthia A Prows, et al.Pageof 112